Berkowitz, Aviva C. http://orcid.org/0000-0003-1687-2500
Halmos, Balazs
Cheng, Haiying
Huntzinger, Cal
Ohri, Nitin
Funding for this research was provided by:
Reflexion Medical, Inc.
Article History
Received: 7 April 2022
Accepted: 20 January 2023
First Online: 9 February 2023
Declarations
:
: Dr. Berkowitz has no relevant financial or non-financial interests to disclose. Dr. Halmos is a consultant at AstraZeneca, Boehringer Ingelheim, Genentech/Roche, Pfizer, Lilly, Foundation Medicine, Guardant Health, Takeda, Novartis, Merck, Bristol-Myers Squibb, Spectrum Pharmaceuticals and TPT Therapeutics. Dr. Cheng is a consultant at AstraZeneca and Bayer, and she received research grants from Roche/Genentech, Spectrum Pharmaceuticals, and Vaccinex. Mr. Huntzinger is an employee at RefleXion Medical, where he also has stock and stock options. Dr. Ohri is a consultant at Merck and AstraZeneca.
: This article does not contain any studies with human or animal subjects performed by any of the authors.